| Name | Title | Contact Details |
|---|---|---|
Scott Tambert |
Director of Technology Solutions and Information Security Officer | Profile |
Armstrong Pharmaceuticals, Inc. was founded in 1955 as a manufacturer of specialty aerosol products. Armstrong produced a wide array of topical, personal care, and pharmaceutical products. Since 1993, Armstrong has focused exclusively on pharmaceutical
SaatiTech is a Somers, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany as well as Ann Arbor, Michigan. InflaRx is listed on the Nasdaq Global Select Market in the United States under the trading symbol “IFRX”.
Nanogenix Inc. is a biotechnology company that focuses on developing and commercializing novel cancer therapies for patients in high unmet need disease categories.
Clyde Chemists is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.